BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16322231)

  • 1. Effects of VHL deficiency on endolymphatic duct and sac.
    Gläsker S; Lonser RR; Tran MG; Ikejiri B; Butman JA; Zeng W; Maxwell PH; Zhuang Z; Oldfield EH; Vortmeyer AO
    Cancer Res; 2005 Dec; 65(23):10847-53. PubMed ID: 16322231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vestibular aqueduct: site of origin of endolymphatic sac tumors.
    Lonser RR; Baggenstos M; Kim HJ; Butman JA; Vortmeyer AO
    J Neurosurg; 2008 Apr; 108(4):751-6. PubMed ID: 18377255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry.
    Bausch B; Wellner U; Peyre M; Boedeker CC; Hes FJ; Anglani M; de Campos JM; Kanno H; Maher ER; Krauss T; Sansó G; Barontini M; Letizia C; Hader C; Schiavi F; Zanoletti E; Suárez C; Offergeld C; Malinoc A; Zschiedrich S; Glasker S; Bobin S; Sterkers O; Ba Huy PT; Giraud S; Links T; Eng C; Opocher G; Richard S; Neumann HP;
    Head Neck; 2016 Apr; 38 Suppl 1():E673-9. PubMed ID: 25867206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endolymphatic sac tumors in von Hippel-Lindau disease: report of three cases.
    Codreanu CM; Duet M; Hautefort C; Wassef M; Guichard JP; Giraud S; Richard S; Roqueplo AP; Tran Ba Huy P
    Otol Neurotol; 2010 Jun; 31(4):660-4. PubMed ID: 20351605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease.
    Manski TJ; Heffner DK; Glenn GM; Patronas NJ; Pikus AT; Katz D; Lebovics R; Sledjeski K; Choyke PL; Zbar B; Linehan WM; Oldfield EH
    JAMA; 1997 May; 277(18):1461-6. PubMed ID: 9145719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel-Lindau disease-related tumours.
    Schweizer L; Thierfelder F; Thomas C; Soschinski P; Kim HY; Jödicke R; Woltering N; Förster A; Teichmann D; Siewert C; Klein K; Schmid S; Nunninger M; Thomale UW; Onken J; Mühleisen H; Schittenhelm J; Tatagiba M; von Deimling A; Reuss DE; Solomon DA; Heppner FL; Koch A; Hartmann C; Staszewski O; Capper D
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):756-767. PubMed ID: 34091929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with atypical pathology of endolymphatic sac tumor.
    Yang X; Liu XS; Fang Y; Zhang XH; Zhang YK
    Int J Clin Exp Pathol; 2014; 7(5):2609-14. PubMed ID: 24966975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with analysis of von Hippel-Lindau gene and review.
    Rao Q; Zhou J; Wang JD; Jin XZ; Ma HH; Lu ZF; Zhou XJ
    Ann Diagn Pathol; 2010 Oct; 14(5):361-4. PubMed ID: 20850701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
    Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
    Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene.
    Skalova A; Síma R; Bohus P; Curík R; Lukás J; Michal M
    Pathol Res Pract; 2008; 204(8):599-606. PubMed ID: 18423895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
    Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Hippel-Lindau disease: surveillance strategy for endolymphatic sac tumors.
    Poulsen ML; Gimsing S; Kosteljanetz M; Møller HU; Brandt CA; Thomsen C; Bisgaard ML
    Genet Med; 2011 Dec; 13(12):1032-41. PubMed ID: 21912262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of erythropoietin and its receptor in endolymphatic sac tumors.
    Vogel TW; Vortmeyer AO; Lubensky IA; Lee YS; Furuta M; Ikejiri B; Kim HJ; Lonser RR; Oldfield EH; Zhuang Z
    J Neurosurg; 2005 Aug; 103(2):284-8. PubMed ID: 16175858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
    Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
    Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
    Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z
    Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
    Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
    Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status.
    Bambakidis NC; Megerian CA; Ratcheson RA
    Otol Neurotol; 2004 Sep; 25(5):773-81. PubMed ID: 15354010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
    Vortmeyer AO; Choo D; Pack S; Oldfield E; Zhuang Z
    Neurology; 2000 Aug; 55(3):460. PubMed ID: 10932304
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls.
    Jester R; Znoyko I; Garnovskaya M; Rozier JN; Kegl R; Patel S; Tran T; Abedalthagafi M; Horbinski CM; Richardson M; Wolff DJ; Lapadat R; Moore W; Rodriguez FJ; Mull J; Olar A
    Acta Neuropathol Commun; 2018 Oct; 6(1):107. PubMed ID: 30340515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.